Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Comparing Early Extension of Aflibercept and Brolucizumab in Wet AMD (SPARROW)

NCT04932980 is registered in ClinicalTrials.gov with Berner Augenklinik as lead sponsor.

NCT NCT04932980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04932980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Comparing Early Extension of Aflibercept and Brolucizumab in Wet AMD (SPARROW)
Lead sponsor
Berner Augenklinik
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 9, 2022
Completion date
March 31, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wet age-related macular degeneration